Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the ...(rior year cash flows from the former fun...)

Date:11/10/2008

rior year cash flows from the former funeral services business while the remainder relates primarily to movements in working capital, including higher receivables associated with strong fourth quarter revenues. Full year cash flow from operations was $270.5 million, down $14.8 million, or 5.2 percent from the prior year, but up over 40 percent after taking into account the current and prior year cash flows from the funeral services business of $56.8 million and $136.2 million, respectively.

-- Income tax expense in the fourth quarter includes discrete period tax benefits of $1.5 million, or $0.02 per fully diluted share, pertaining to various tax matters resolved during the quarter. The prior year period included a lesser amount of discrete tax benefits.

Please see the attached schedules for additional information, including reconciliations of earnings in accordance with U.S. generally accepted accounting principles ("GAAP") to as adjusted income and earnings per share, condensed financial information, summary balance sheet information, and segment sales summaries.

For a more complete review of Hill-Rom's results, please refer to our Annual Report on Form 10-K for the year ended September 30, 2008, which will be filed later this month.

Financial Guidance Summary For 2009

Management reaffirmed full year 2009 guidance initially provided on October 7, 2008 in conjunction with Hill-Rom's investor conference: Hill-Rom's consolidated revenue guidance range for fiscal 2009 is expected to be $1.633 - $1.683 billion; earnings per fully diluted share from continuing operations is expected to be $1.40 - $1.64. This guidance includes the results from our Liko acquisition for a full twelve months. Financial guidance in tabular format is included as an attachment.

Hill-Rom Holdings, Inc. provides earnings per share guidance on an adjusted basis from continuing operations because the company's management believes that the presentation prov
'/>"/>

SOURCE Hill-Rom Holdings, Inc. Copyright©2008 PR Newswire. All rights reserved

1 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19
Related biology technology :

1. Hill-Rom Introduces New Wound Therapy Surface With Innovative Safety and Treatment Features
2. Trubion Pharmaceuticals Inc. Reports Third Quarter and Nine Months 2008 Results
3. Medivation Reports Third Quarter 2008 Financial Results and Provides Corporate Update
4. BMP Sunstone Reports Third Quarter 2008 Financial Results
5. Endocare Reports Financial Results for Third Quarter 2008
6. Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs
7. Isis Reports Financial Results and Highlights for Third Quarter of 2008
8. OncoGenex Reports Third Quarter Financial Results
9. American Oriental Bioengineering Reports Third Quarter 2008 Financial Results
10. AutoImmune Inc. Reports 2008 Third Quarter Financial Results
11. Dendreon Reports Third Quarter 2008 Financial Results